Send us Fan Mail

In this episode of the Life Science Success Podcast my guest is Dean Erhardt, President and CEO at D2 Solutions. He brings more than 20 years of experience across pharmaceuticals and consumer products, with expertise in support program development, distribution, and specialty product management, and has worked with over 100 pharmaceutical, biotech, and medical device manufacturers as well as many small and midsized organizations on commercial operations, strategy, and national accounts.

00:00 Intro

00:34 Dean's career: HMO, Cardinal Health, Express Scripts

03:00 Founding D2 Solutions in 2008

04:00 Pricing strategy and middlemen taking 50–70% of revenue

08:00 What separates successful commercialization from failure

10:00 D2's three pillars: distribution, reimbursement, patient services

15:00 Pharmaceutical support programs for specialty medications

16:00 D2's digital patient engagement platform in action

21:00 Resource challenges for small and mid-sized pharma

22:00 Retail deserts and the rise of direct-to-consumer models

24:00 National accounts strategy and long-term payer relationships

26:00 When to engage D2 and cleaning up commercialization missteps

28:00 The prior authorization crisis

31:00 Leadership advice: one vision, said a million times

32:00 AI, remote surgery, and the future of care

34:00 Looming shortage of 3.9 million healthcare workers

36:00 Concerns: aging population, lost patients, NIH funding

37:00 Technology accelerating drug approvals

38:00 Outro

Send us Fan Mail

Jesse Mendelsohn and Michael Grosberg from Model N discuss why U.S. pricing complexity is spreading globally, the collapse of the PBM rebate model, what's really driving the pharmaceutical manufacturing boom, and why direct-to-consumer discount programs won't solve America's drug access problem.

00:00 Introduction to Life Science Success Podcast
00:34 Pressing Issues in Pharmaceutical Manufacturing
00:51 Introducing the Experts from Model N
03:08 Understanding International Reference Pricing
04:14 Impact of US Pricing on Global Drug Launches
09:26 Challenges with Pharmacy Benefit Managers
16:29 Domestic Manufacturing Boom in Pharmaceuticals
23:08 AI in Drug Discovery and Personalized Medicine
29:03 Access and Policy Discussion
30:01 Direct to Consumer Pricing
31:32 TrumpRx Overview
33:11 Compliance Challenges
38:30 Pharmaceutical Revenue Management
41:38 AI in Life Sciences
48:35 Future of Life Sciences
50:45 Concerns and Challenges
53:52 Excitement in Current Work
55:54 Conclusion and Final Thoughts

Send us Fan Mail

In this episode of the Life Science Success Podcast my guest is Troy Fugate. The CCO of Compliance Insight, Inc., Troy brings 30+ years of FDA readiness, GMP, and quality leadership—turning complex requirements into practical, culture-shaping solutions and championing the Align–Apply–Adapt framework used across pharma, cell and gene therapy, and medical devices.

00:00 Introduction to Life Science Success Podcast

00:37 Meet Troy Fugate: CCO of Compliance Insight

01:09 Troy's Career Journey and FDA Focus

04:10 The Align, Apply, Adapt Framework

04:47 Differentiating Compliance Insight

08:03 The Importance of Clarity in Compliance

17:10 Challenges and Solutions in Compliance

25:38 Human Behavior and Continuous Improvement

34:39 Troy's Inspirations and Concerns

39:07 Final Thoughts and Closing Remarks